Long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular disease

Oral anticoagulant alone and DOAC with antiplatelet therapy were associated with higher risks of major bleeding events than SAPT in long-term follow-up for patients with stroke and cardiovascular disease.